Screener
Edwards Lifesciences EW Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Operating lease liabilities | 24.3 | 24.5 |
| Total current liabilities | 1,409.0 | 1,813.7 |
| Long-term debt | 598.5 | 598.3 |
| Operating lease liabilities | 80.1 | 82.6 |
| Uncertain tax positions | 555.4 | 502.7 |
| Other liabilities | 350.7 | 362.3 |
| Total liabilities | 2,993.7 | 3,359.6 |
| Commitments and contingencies (Note 12) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edwards Lifesciences's operating lease liabilities?
- Edwards Lifesciences (EW) reported operating lease liabilities of $80.1M in Q1 2026.
- How has Edwards Lifesciences's operating lease liabilities changed year-over-year?
- Edwards Lifesciences's operating lease liabilities increased by 2.8% year-over-year, from $77.9M to $80.1M.
- What is the long-term trend for Edwards Lifesciences's operating lease liabilities?
- Over 5 years (2020 to 2025), Edwards Lifesciences's operating lease liabilities has grown at a 2.6% compound annual growth rate (CAGR), from $72.7M to $82.6M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Edwards Lifesciences's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude